WORCESTER – After a snag in 2024, the construction of WuXi Biologics has resumed. The company is aiming to complete its Worcester location in 2028, said a spokesperson for the Chinese pharmaceutical ...

A Chinese biotechnology company sued the US government on Thursday over being placed on a list of businesses from China that the ‌US Department of Defence has linked to that country’s military. WuXi ...

June 11 (Reuters) - A Chinese biotechnology company sued the U.S. government on Thursday over being placed on a list of businesses from ‌China that the U.S. Department of Defense has linked to that ...

Shares of Chinese pharmaceutical major WuXi AppTec tumbled after the U.S. Defense Department added the company to its list of entities deemed to have ties with Beijing's military. WuXi AppTec's Hong ...

For nearly two years, WuXi AppTec, the Chinese contract research giant with extensive ties with U.S. biotech and pharmaceutical companies, operated under cloud, as Congress threatened to restrict its ...

WuXi Biologics' pre-filled syringes (PFS) commercial production line passed its first FDA inspection, paving the way for global delivery of high-quality PFS solutions to clients worldwide Reinforces ...

WuXi Biologic's facility in Worcester, seen here in December. Progress at the site has been slow, as the China-based firm has sold off some of its international assets. PHOTO ERIC CASEY CORRECTION: ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min WuXi STA expects to hire about ...

WuXi AppTec Co. and WuXi Biologics Cayman Inc. said they see a brighter 2025 for the Chinese biotech and drug companies after the US Biosecure legislation that threatened to cut them out from their ...

CDMO WuXi Biologics signed a deal with Candid Therapeutics, a clinical-stage biotechnology company, giving Candid exclusive global rights to a preclinical trispecific T-cell engager discovered on WuXi ...

China's WuXi AppTec has agreed to sell a business unit serving the cell and gene therapy (CGT) sector to private equity firm Altaris for an undisclosed sum. The contract development and manufacturing ...

(Reuters) -China's WuXi AppTec said on Tuesday its subsidiaries have signed a deal with U.S.-based private equity firm Altaris LLC for the sale of its cell and gene therapy manufacturing unit, WuXi ...